{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:09:02Z","timestamp":1794856142073,"version":"4.9.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,11,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the efficacy and safety of daily tadalafil, a potent selective phosphodiesterase 5 inhibitor, for the treatment of erectile dysfunction (ED) in men previously unresponsive to on-demand tadalafil.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>A total of 112 men with a mean age of 63 (range 21\u201379) and moderate to severe ED of various aetiologies were treated with tadalafil, taken on a daily basis at flexible daily doses of 10 and 20 mg for 12 weeks. The three primary outcomes were changes from the pretreatment and on-demand tadalafil baseline in the erectile function domain of the International Index of Erectile Function and the proportion of yes responses to questions 2 and 3 of the Sexual Encounter Profile. Additional efficacy instruments included a Global Assessment Question administered at completion of the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with pretreatment and on-demand tadalafil baseline, daily dosed tadalafil significantly enhanced all efficacy outcome variables. Patients receiving daily tadalafil (10 mg) experienced a significant mean improvement of 12.8 and 8.2 in the International Index of Erectile Function erectile function domain score from baseline (P &amp;lt; 0.001) and from on-demand tadalafil, respectively (P &amp;lt; 0.001). Fifty-eight percent of intercourse attempts (Sexual Encounter Profile question 3) were successfully completed (P &amp;lt; 0.001 vs. pretreatment baseline, P &amp;lt; 0.001 vs. on-demand tadalafil). Improved erections at end point were reported by 69% of men compared with 42% of men with on-demand tadalafil. Daily tadalafil was well tolerated with headache, dyspepsia, and facial flushing as the most frequent adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Daily tadalafil (10\/20 mg) was effective and well tolerated in this study population and is an effective salvage for previous on-demand tadalafil nonresponders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1743-6109.04042.x","type":"journal-article","created":{"date-parts":[[2004,10,13]],"date-time":"2004-10-13T10:00:40Z","timestamp":1097661640000},"page":"292-300","source":"Crossref","is-referenced-by-count":99,"title":["Efficacy and Safety of Daily Tadalafil in Men with Erectile Dysfunction Previously Unresponsive to On-Demand Tadalafil"],"prefix":"10.1093","volume":"1","author":[{"given":"Chris","family":"McMahon","sequence":"first","affiliation":[{"name":"Australian Centre for Sexual Health , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,11,1]]},"reference":[{"key":"2024032600074629700_bib1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/jama.281.6.537","article-title":"Sexual dysfunction in the United States: Prevalence and predictors","volume":"281","author":"Laumann","year":"1999","journal-title":"JAMA"},{"key":"2024032600074629700_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"key":"2024032600074629700_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(85)92023-9","article-title":"Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men","volume":"1","author":"Virag","year":"1985","journal-title":"Lancet"},{"key":"2024032600074629700_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0895-7061(98)00225-8","article-title":"The prevalence and etiology of impotence in 101 male hypertensive outpatients","volume":"12","author":"Jensen","year":"1999","journal-title":"Am J Hypertens"},{"key":"2024032600074629700_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-5347(17)37759-5","article-title":"Hypercholesterolemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle","volume":"146","author":"Azadzoi","year":"1991","journal-title":"J Urol"},{"key":"2024032600074629700_bib6","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0022-5347(17)37676-0","article-title":"Erectile dysfunction due to atherosclerotic vascular disease: The development of an animal model","volume":"147","author":"Azadzoi","year":"1992","journal-title":"J Urol"},{"key":"2024032600074629700_bib7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJM198904203201601","article-title":"Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence","volume":"320","author":"Saenz de Tejada","year":"1989","journal-title":"N Engl J Med"},{"key":"2024032600074629700_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jacc.2003.07.042","article-title":"Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease","volume":"43","author":"Kaiser","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2024032600074629700_bib9","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfunction","volume":"338","author":"Goldstein","year":"1998","journal-title":"N Engl J Med"},{"key":"2024032600074629700_bib10","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/S0022-5347(05)64442-4","article-title":"Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses","volume":"168","author":"Brock","year":"2002","journal-title":"J Urol"},{"key":"2024032600074629700_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0090-4295(03)00359-5","article-title":"Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: A randomized controlled trial","volume":"62","author":"Porst","year":"2003","journal-title":"Urology"},{"key":"2024032600074629700_bib12","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1097\/01.ju.0000096221.67967.ae","article-title":"Salvage of sildenafil failures referred from primary care physicians","volume":"170","author":"Atiemo","year":"2003","journal-title":"J Urol"},{"key":"2024032600074629700_bib13","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.1365-2265.2003.01764.x","article-title":"Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction","volume":"58","author":"Aversa","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032600074629700_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/tam.6.2.94.99","article-title":"Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone","volume":"6","author":"Kalinchenko","year":"2003","journal-title":"Aging Male"},{"key":"2024032600074629700_bib15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.ijir.3900936","article-title":"High dose sildenafil citrate as a salvage therapy for severe erectile dysfunction","volume":"14","author":"McMahon","year":"2002","journal-title":"Int J Impot Res"},{"key":"2024032600074629700_bib16","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/S0022-5347(05)68085-8","article-title":"Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy","volume":"162","author":"McMahon","year":"1999","journal-title":"J Urol"},{"key":"2024032600074629700_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000020248","article-title":"Initial results utilizing combination therapy for patients with a suboptimal response to either alprostadil or sildenafil monotherapy","volume":"38","author":"Mydlo","year":"2000","journal-title":"Eur Urol"},{"key":"2024032600074629700_bib18","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2337\/diacare.25.12.2159","article-title":"Effects of tadalafil on erectile dysfunction in men with diabetes","volume":"25","author":"Saenz de Tejada","year":"2002","journal-title":"Diabetes Care"},{"key":"2024032600074629700_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.281.5.421","article-title":"Sildenafil for treatment of erectile dysfunction in men with diabetes: A randomized controlled trial","volume":"281","author":"Rendell","year":"1999","journal-title":"JAMA"},{"key":"2024032600074629700_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2337\/diacare.26.2.279","article-title":"Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: Results of a randomized controlled trial","volume":"26","author":"Stuckey","year":"2003","journal-title":"Diabetes Care"},{"key":"2024032600074629700_bib21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2337\/diacare.26.3.777","article-title":"Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: A multicenter double-blind placebo-controlled fixed-dose study","volume":"26","author":"Goldstein","year":"2003","journal-title":"Diabetes Care"},{"issue":"H suppl","key":"2024032600074629700_bib22","doi-asserted-by":"crossref","first-page":"H32","DOI":"10.1016\/S1520-765X(02)90050-7","article-title":"Overview of the cardiovascular effects of tadalafil","volume":"4","author":"Emmick","year":"2002","journal-title":"Eur Heart J"},{"key":"2024032600074629700_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.amjhyper.2003.09.006","article-title":"Erectile dysfunction in essential arterial hypertension and effects of sildenafil: Results of a Spanish national study","volume":"17","author":"Aranda","year":"2004","journal-title":"Am J Hypertens"},{"key":"2024032600074629700_bib24","first-page":"S49","article-title":"Sildenafil (Viagra) is effective in the treatment of severe male erectile dysfunction","volume":"10","author":"Steers","year":"1998","journal-title":"Int J Impot Res"},{"key":"2024032600074629700_bib25","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/01.ju.0000086947.00547.49","article-title":"Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy","volume":"170","author":"Brock","year":"2003","journal-title":"J Urol"},{"key":"2024032600074629700_bib26","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/S0022-5347(05)68179-7","article-title":"Sildenafil citrate after radical retropubic prostatectomy","volume":"162","author":"Lowentritt","year":"1999","journal-title":"J Urol"},{"issue":"1 Suppl","key":"2024032600074629700_bib27","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1038\/sj.ijir.3900466","article-title":"Time dependent patient satisfaction with sildenafil for erectile dysfunction (ED) after nerve-sparing radical retropubic prostatectomy (RRP)","volume":"11","author":"Hong","year":"1999","journal-title":"Int J Impot Res"},{"key":"2024032600074629700_bib28","article-title":"Cialis\u00ae (tadalafil HCI) tablets: Prescribing information (online)","author":"Eli Lilly Corporation"},{"key":"2024032600074629700_bib29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-8703(91)90861-B","article-title":"Cardiovascular disease risk profiles","volume":"121","author":"Anderson","year":"1991","journal-title":"Am Heart J"},{"key":"2024032600074629700_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9149(00)00896-1","article-title":"Management of sexual dysfunction in patients with cardiovascular disease: Recommendations of the Princeton Consensus Panel","volume":"86","author":"DeBusk","year":"2000","journal-title":"Am J Cardiol"},{"key":"2024032600074629700_bib31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0022-5347(05)65866-1","article-title":"Long-term efficacy of sildenafil and tachyphylaxis effect","volume":"166","author":"El-Galley","year":"2001","journal-title":"J Urol"},{"key":"2024032600074629700_bib32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/sj.ijir.3900714","article-title":"Assessment of the efficacy and safety of Viagra (sildenafil citrate) in men with erectile dysfunction during long-term treatment","volume":"13","author":"Steers","year":"2001","journal-title":"Int J Impot Res"},{"key":"2024032600074629700_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1043-2760(98)00127-1","article-title":"Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor","volume":"10","author":"Moreland","year":"1999","journal-title":"Trends Endocrinol Metab"},{"issue":"1 suppl","key":"2024032600074629700_bib34","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1038\/sj.ijir.3900465","article-title":"Sildenafil causes a dose- and time-dependent downregulation of phosphodiesterase type 6 expression in the rat retina","volume":"11","author":"Gonzalez","year":"1999","journal-title":"Int J Impot Res"},{"key":"2024032600074629700_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.ijir.3900802","article-title":"Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters","volume":"14","author":"Lin","year":"2002","journal-title":"Int J Impot Res"},{"key":"2024032600074629700_bib36","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/01.ju.0000075500.11519.e8","article-title":"Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism","volume":"170","author":"Lin","year":"2003","journal-title":"J Urol"},{"key":"2024032600074629700_bib37","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0022-5347(18)38816-5","article-title":"Long-term treatment with high doses of sildenafil does not up-regulate the levels of phosphodiesterase 5 (PDE5) in the rat penis","volume":"171","author":"Ferrini","year":"2004","journal-title":"J Urol"},{"key":"2024032600074629700_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0022-5347(18)38819-0","article-title":"Chronic sildenafil enhances erectile responses and endothelium-dependent corporal relaxations of normal rats: Lack of tachyphylaxis","volume":"171","author":"Behr-Roussel","year":"2004","journal-title":"J Urol"},{"key":"2024032600074629700_bib39","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0735-1097(02)02139-3","article-title":"The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia","volume":"40","author":"Halcox","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2024032600074629700_bib40","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2337\/diacare.25.8.1336","article-title":"Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes","volume":"25","author":"Desouza","year":"2002","journal-title":"Diabetes Care"},{"key":"2024032600074629700_bib41","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.HYP.0000068202.42431.CC","article-title":"PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers","volume":"41","author":"Kimura","year":"2003","journal-title":"Hypertension"},{"key":"2024032600074629700_bib42","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0735-1097(00)00790-7","article-title":"Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure","volume":"36","author":"Katz","year":"2000","journal-title":"J Am Coll Cardiol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515310766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515310766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/1\/3\/292\/47522410\/jsm_1_3_292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/1\/3\/292\/47522410\/jsm_1_3_292.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T21:05:20Z","timestamp":1711400720000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/1\/3\/292\/6863028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,1]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2004,11,1]]},"published-print":{"date-parts":[[2004,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.04042.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,11]]},"published":{"date-parts":[[2004,11,1]]}}}